Lobaplatin induces pyroptosis through regulating cIAP1/2, Ripoptosome and ROS in nasopharyngeal carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lobaplatin induces pyroptosis through regulating cIAP1/2, Ripoptosome and ROS in nasopharyngeal carcinoma

Published:2020-07 Issue: Volume:177 Page:114023
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Chen Zide,Xu Gang,Wu Dong,Wu Shihai,Gong Long,Li Zihuang,Luo Guanghong,Hu Jian,Chen Jian,Huang Xiaoting,Chen Chengcong,Jiang Zhenyou,Li Xianming

Funder

China Postdoctoral Science Foundation

Special Foundation for the Development of Strategic Emerging Industries of Shenzhen

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference29 articles.

1. NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017

2. Cisplatin: a review of toxicities and therapeutic applications;Barabas;Vet. Comp. Oncol.,2008

3. Functionalization of Platinum Complexes for Biomedical Applications;Wang;Acc. Chem. Res.,2015

4. Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients based on induction chemotherapy response;Liu;Radiother. Oncol.,2019

5. Comparison of long-term survival and toxicity of cisplatin delivered weekly versus every three weeks concurrently with intensity-modulated radiotherapy in nasopharyngeal carcinoma;Tao;PLoS ONE,2014

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Photocatalytic Carbon Dots‐Triggered Pyroptosis for Whole Cancer Cell Vaccines;Advanced Materials;2024-08-12

2. The interplay of transition metals in ferroptosis and pyroptosis;Cell Division;2024-08-03

3. Lobaplatin-based concurrent chemoradiotherapy in elderly nasopharyngeal carcinoma;Annals of Medicine;2024-07-31

4. ROS induced pyroptosis in inflammatory disease and cancer;Frontiers in Immunology;2024-07-01

5. Therapeutic strategies of targeting non-apoptotic regulated cell death (RCD) with small-molecule compounds in cancer;Acta Pharmaceutica Sinica B;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3